AKTX

Akari Therapeutics
AKTX

13 hedge funds and large institutions have $15.1M invested in Akari Therapeutics in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$428K
2
+$60.9K
3
+$40.2K
4
HNB
Huntington National Bank
Ohio
+$37.5K
5
Deutsche Bank
Deutsche Bank
Germany
+$18.3K

Top Sellers

1
-$1.8M
2
-$853K
3
-$531K
4
Millennium Management
Millennium Management
New York
-$462K
5
AG
Advisor Group
Arizona
-$29.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$3.05M
2
$2.78M
3
$2.66M
4
$2.62M
5
$2.12M
6
$929K
7
$709K
8
$123K
9
$54K
10
$49K
11
$32K
12
$13K
13
–
14
–
15
–